132 related articles for article (PubMed ID: 11774244)
1. Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen.
Huarte E; Sarobe P; Lasarte JJ; Brem G; Weiss EH; Prieto J; Borrás-Cuesta F
Int J Cancer; 2002 Jan; 97(1):58-63. PubMed ID: 11774244
[TBL] [Abstract][Full Text] [Related]
2. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
Kawashima I; Tsai V; Southwood S; Takesako K; Sette A; Celis E
Cancer Res; 1999 Jan; 59(2):431-5. PubMed ID: 9927058
[TBL] [Abstract][Full Text] [Related]
3. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
4. Identification of a MHC class-II restricted epitope in carcinoembryonic antigen.
Shen L; Schroers R; Hammer J; Huang XF; Chen SY
Cancer Immunol Immunother; 2004 May; 53(5):391-403. PubMed ID: 14624313
[TBL] [Abstract][Full Text] [Related]
5. Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.
Schmitz J; Reali E; Hodge JW; Patel A; Davis G; Schlom J; Greiner JW
Cancer Res; 2002 Sep; 62(17):5058-64. PubMed ID: 12208761
[TBL] [Abstract][Full Text] [Related]
6. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
Kobayashi H; Omiya R; Ruiz M; Huarte E; Sarobe P; Lasarte JJ; Herraiz M; Sangro B; Prieto J; Borras-Cuesta F; Celis E
Clin Cancer Res; 2002 Oct; 8(10):3219-25. PubMed ID: 12374692
[TBL] [Abstract][Full Text] [Related]
7. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.
Huarte E; Sarobe P; Lu J; Casares N; Lasarte JJ; Dotor J; Ruiz M; Prieto J; Celis E; Borrás-Cuesta F
Clin Cancer Res; 2002 Jul; 8(7):2336-44. PubMed ID: 12114438
[TBL] [Abstract][Full Text] [Related]
8. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
[TBL] [Abstract][Full Text] [Related]
9. Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine.
Wu Y; Wan T; Zhou X; Wang B; Yang F; Li N; Chen G; Dai S; Liu S; Zhang M; Cao X
Cancer Res; 2005 Jun; 65(11):4947-54. PubMed ID: 15930317
[TBL] [Abstract][Full Text] [Related]
10. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
11. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential HLA-A *0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA).
Ras E; van der Burg SH; Zegveld ST; Brandt RM; Kuppen PJ; Offringa R; Warnarr SO; van de Velde CJ; Melief CJ
Hum Immunol; 1997 Mar; 53(1):81-9. PubMed ID: 9127151
[TBL] [Abstract][Full Text] [Related]
13. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
Lu J; Celis E
Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651
[TBL] [Abstract][Full Text] [Related]
14. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
Cheuk E; Chamberlain JW
Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a T-helper peptide from carcinoembryonic antigen.
Ruiz M; Kobayashi H; Lasarte JJ; Prieto J; Borrás-Cuesta F; Celis E; Sarobe P
Clin Cancer Res; 2004 Apr; 10(8):2860-7. PubMed ID: 15102695
[TBL] [Abstract][Full Text] [Related]
16. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
[TBL] [Abstract][Full Text] [Related]
18. HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy.
Fauquembergue E; Toutirais O; Tougeron D; Drouet A; Le Gallo M; Desille M; Cabillic F; de La Pintière CT; Iero M; Rivoltini L; Baert-Desurmont S; Leprince J; Vaudry H; Sesboué R; Frébourg T; Latouche JB; Catros V
J Immunother; 2010 May; 33(4):402-13. PubMed ID: 20386466
[TBL] [Abstract][Full Text] [Related]
19. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
20. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.
Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J
Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
